Patients With Higher TyG Index And Hyperuricemia At Higher Risk Of MACE After CABG
- byDoctor News Daily Team
- 13 July, 2025
- 0 Comments
- 0 Mins
China: A recent study has suggested combining the TyG index and SUA (serum uric acid) is more accurate for assessing cardiovascular risk in patients undergoing CABG (coronary artery bypass grafting). The patients with higher TyG index and hyperuricemia were revealed to be at higher risk of MACE.
The multicenter, retrospective cohort study revealed that in patients undergoing CABG, the TyG (triglyceride-glucose) index interacts synergistically with SUA to increase the MACE (major adverse cardiovascular events) risk in patients undergoing CABG. The study appeared in Cardiovascular Diabetology on 02 May 2023.
Previous studies have shown elevated serum uric acid as a risk factor for cardiovascular disease development. TyG index is a novel surrogate for insulin resistance and has been proven to be an independent predictor for adverse cardiac events. No study, however, has specifically focused on the interaction between the two metabolic risk factors. Therefore, Zhenguo Wu, Qilu Hospital of Shandong University, Jinan, Shandong, China, and colleagues aimed to determine if the SUA and TyG index combination could result in a more accurate prognostic prediction in patients undergoing CABG in a multicenter, retrospective cohort study.
The study included a total of 1225 patients who underwent CABG. The patients were grouped based on the sex-specific criteria of hyperuricemia (HUA) and the cut-off value of the TyG index. The interaction between the TyG index and serum uric acid was estimated using attributable proportion (AP), synergy index (SI), and relative excess risk due to interaction (RERI).
The model performance improvement yielded by including the TyG index and SUA was examined by net reclassification improvement (NRI), C-statistics, and integrated discrimination improvement (IDI). The goodness-of-fit of models was assessed using the χ2 likelihood ratio test, Bayesian information criterion (BIC), and Akaike information criterion (AIC).
The study revealed the following findings:
· During follow-up, 263 patients developed MACE.
· The joint and independent associations of the TyG index and serum uric acid with adverse events were significant.
Patients having higher TyG index and hyperuricemia were at higher risk of MACE.
· The authors found a significant synergistic interaction between the TyG index and SUA [RERI: 1.83; AP: 0.41; SI: 2.13].
· There was a significant improvement in prognostic prediction and model fit [change in C-statistic: 0.038; continuous NRI: 0.336; IDI: 0.031; AIC: 3534.29; BIC: 3616.45) on the addition of the TyG index and SUA.
The study revealed the predictive value of the SUA and the TyG index in patients who underwent CABG.
"Our findings provided novel information on the synergistic interaction between the serum uric acid and TyG index," the researchers wrote. "The SUA and TyG index combination could be proposed as a beneficial prognostic indicator in post-CABG patients."
Reference:
Wu, Z., Cheng, C., Sun, X. et al. The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study. Cardiovasc Diabetol 22, 103 (2023). https://doi.org/10.1186/s12933-023-01838-z
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!